Increased neurofibrillary tangles in patients with alzheimer disease with comorbid depression

American Journal of Geriatric Psychiatry

Volumn 16, Issue 2, 2008, Pages 168-174

  Rapp, Michael A ^a,b   Schnaider Beeri, Michal ^a   Purohit, Dushyant P ^a,c   Perl, Daniel P ^a   Haroutunian, Vahram ^a,c   Sano, Mary ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Depression; Neuropathology

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; COGNITION; CONTROLLED STUDY; DATA BASE; DEPRESSION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OUTCOME ASSESSMENT; RATING SCALE; STAGING; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HIPPOCAMPUS; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK; RISK FACTOR; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; ODDS RATIO; RISK FACTORS; SENILE PLAQUES;

EID: 43349100533     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e31816029ec     Document Type: Article

References (38)

1. Braak H, Braak E: Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand 1996; 165:3-12
2. Ogomori K, Kitamoto T, Tateishi J, et al: Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 1989; 134:243-251
3. Mirra SS, Heyman A, McKeel D, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486
4. Braak H, Braak E: Pathology of Alzheimer's disease, in: Neurodegenerative Diseases. Edited by Calne DB. Philadelphia, WB Saunders, 1994; pp 585-613
5. Green RC, Cupples LA, Kurz A, et al: Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol 2003; 60:753-759
6. Steffens DC, Payne ME, Greenberg DL, et al: Hippocampal volume and incident dementia in geriatric depression. Am J Geriatr Psychiatry 2002; 10:62-71
7. Chen P, Ganguli M, Mulsant BH, et al: The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 1999; 56:261-266
8. Jorm AF, van Duijn CM, Chandra V, et al: Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case- control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991; 20:S3-S7
9. Kokmen E, Beard CM, Chandra V, et al: Clinical risk factors for Alzheimer's disease: a population-based case- control study. Neurology 1991; 41:1393-1397
10. Van Duijn CM, Clayton DG, Chandra V, et al: Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case- control studies. EURODEM Risk Factors Research Group. Genet Epidemiol 1994; 11:539-551
11. Speck CE, Kukull WA, Brenner DE, et al: History of depression as a risk factor for Alzheimer's disease. Epidemiology 1995; 6:366-369
12. Devanand DP, Sano M, Tang MX, et al: Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53:175-182
13. Wilson RS, Barnes LL, Mendes de Leon CF, et al: Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002; 59:364-370
14. Rapp MA, Schnaider-Beeri M, Grossman H, et al: Increased hippocampal plaques and tangles in Alzheimer's disease patients with a lifetime history of major depression. Arch Gen Psychiatry 2006; 63:161-167
15. Rapp MA, Dahlman K, Sano M, et al: Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry 2005; 162:691-698
16. Sheline YI, Gado MH, Kraemer HC: Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160:1516-1518
17. Bell-McGinty S, Butters MA, Meltzer CC, et al: Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry 2002; 159:1424-1427
18. Dwivedi Y, Rao JS, Rizavi S, et al: Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60:804-815
19. Yamada Y, Yamamoto M, Ozawa H, et al: Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm 2003; 110:671-680
20. Sw,Ind) mice. PNAS 2004; 101:13363-13367
21. Sweet RA, Hamilton RL, Butters MA, et al: Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology 2004; 8:346-354
22. Nitsch RM, Deng M, Growdon JH, et al: Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem 1996; 271:4188-4194
23. Buxbaum JD, Koo EH, Greengard P: Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. PANAS 1993; 90:9195-9198
24. Mirra SS: The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging 1997; 18:S91-94
25. Braak H, Braak E: Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997; 18:S85-88
26. McKhann G, Drachman D, Folstein MF, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984; 34: 939-944
27. Beeri MS, Rapp M, Silverman JM, et al: Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology 2006; 66:1399-1404
28. nd Ed. Hillsdale, N.J., Lawrence A. Erlbaum Associates, 1988
29. Gorelick PB: Risk factors for vascular dementia and Alzheimer disease. Stroke 2004; 35(suppl 1):2620-2622
30. Lovestone S: Early diagnosis and the clinical genetics of Alzheimer's disease. J Neurol 1999; 246:69-72
31. Knopman D, Donahue JA, Gutterman EM: Patterns of care in the early stages of Alzheimer's disease: impediments to timely diagnosis. J Am Geriatr Soc 2000; 48:300-304
32. Blazer DG: Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 2003; 58:249-265
33. Olin JT, Katz IR, Meyers BS, et al: Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am J Geriatr Psychiatry 2002; 10:129-141
34. Wiener P, Alexopoulos GS, Kakuma T, et al: The limits of historytaking in geriatric depression. Am J Geriatr Psychiatry 1997; 5:116-125
35. Henkel V, Mergl R, Kohnen R, et al: Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups. Gen Hosp Psychiatry 2004; 26:190-198
36. Bondareff W, Mountjoy CQ: number of neurons in nucleus locus ceruleus in demented and non-demented patients: rapid estimation and correlated parameters. Neurobiol Aging 1986; 7:297-300
37. Lyness SA, Zarow C, Chui HC: Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 2003; 24:1-23
38. O'Hara R, Schroder CM, Mahadevan R, et al: Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry 2007 Mar 13; [Epub ahead of print]